Lecture 34 Flashcards
How does inflammation increase risk of cancer?
results in persistent regenerative cell proliferation or hyperplasia and DNA damage as a result reactive oxygen and nitrogen species
long unhealed skin wounds characterized by persistent damage can lead to skin cancer
cirrhosis of the liver can lead to hepatocellular carcinoma
How viruses may cause cancer
Integration into the genome can cause modulation of oncogenes or tumor suppressor genes
HBV and HCV causes hepatitis which increases the risk of liver cancer through inflammation
Expression of viral genes that alter cellular pathways
Sequence of genetic changes associated with colon carcinogenesis
- Loss of APC gene resulting in hyperproliferative colonic epithelium
- DNA methylation (promoter) results in loss of expression of other APC gene (2nd hit) resulting in translocation of the b-catenin protein to the nucleus, where it stimulates Myc and Cyclin D transcription. This results in an early adenoma (benign tumor).
- GOF mutation of ras gene resulting in an intermediate adenoma
- LOF mutation of the DCC, SMAD2 and SMAD4 tumor suppressor genes resulting in adenoma
- Loss of mutation of p53 gene and subsequent additional genetic changes. This results in carcinoma
B cell infections kept silent by functional T cells
cancers caused by these viruses are frequent observed in AIDS patients and other immunocompromised patients
EBV expresses LMP1 and LMP2 which are cell surface receptors that activate mitogenic signaling pathways
Merkel cell polyomavirus
MCPV causes merkel cell carcinoma of the skin
Requires both infection and then mutation of large T antigen to form a truncated version
mostly found in elderly
HPV
causes cervical cancer in women of all ages because of the viral proteins E6 targets p53, and E7 targets Rb
HTLV-1
produces the TAX protein in the host cell
TAX binds to host proteins to increase the expression of genes that promote proliferation, DNA repair, and resistance to apoptosis
Molecular diagnosis of breast cancer
FISH to estimate gene copy number or immunohistochemistry to assess protein expression
BCR-ABL translocation
ER expression in breast cancer correlates with responsiveness to anti-hormone therapy
HER2 overexpression and anti-HER2 antibodies